Full name
BIORENIX SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice activities
47.19.Z - Other retail sale in non-specialised stores
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
58.19.Z - Other publishing activities
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 4,3 | -0,5 | 0,6 | 209,6 |
EBITDA | 4,3 | -0,6 | 0,5 | 185,9 |
Short time liabilities | 1,6 | 2,5 | 2,2 | -13 |
Equity capital | 6,9 | 6,3 | 6,9 | 9 |
Operating profit (EBIT) | 4,3 | -0,6 | 0,5 | 185,9 |
Assets | 8,5 | 8,8 | 9,1 | 2,8 |
Net profit (loss) | 3,9 | -0,5 | 0,6 | 204,3 |
Cash | 7,3 | 6,8 | 6,6 | -3,3 |
Net income from sale | 113,4 | 113,9 | 122,4 | 7,4 |
Liabilities and provisions for liabilities | 1,6 | 2,5 | 2,2 | -13 |
Working assets | 8,5 | 8,8 | 9,1 | 2,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 57,2 | -8,6 | 8,3 | 16,9 |
Equity capital to total assets | 81,5 | 72 | 76,3 | 4,3 |
Gross profit margin | 3,8 | -0,5 | 0,5 | 1 |
EBITDA Margin | 3,8 | -0,5 | 0,4 | 0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 5 | 8 | 6 | -2 |
Current financial liquidity indicator | 5.398490905761719 | 3.568971872329712 | 4.216553688049316 | 0,6 |
Net dept to EBITDA | -1.6986565589904785 | 11.365547180175781 | -12.79554271697998 | -24,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane